Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alpha Halogenated Trifluoromethyl Substituted Alkane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111303089B details a mild Mn-mediated trifluoromethylation. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable room temperature processes.